CIRM: get a little closer

In its latest batch of grants the California Institute for Regenerative Medicine divided a smaller pool of funding among fewer research teams than it did in 2009, reflecting the institute's interest in funding projects that are close to entering the clinic.

Last month, CIRM announced awards totaling $151 million to teams from 7 academic institutions and 1 company-StemCells Inc.-that are expected to submit INDs or complete Phase I or Phase II testing when work on the 4-year grants is complete (see "2012 CIRM grants")...